|
Relationship between MRD and PET responses and PFS in previously untreated follicular lymphoma in the GALLIUM trial. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Gilead Sciences; Janssen; Pfizer; Roche |
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche; Takeda |
Research Funding - Accera; BMS Brazil; Celgene; CTI; Gilead Sciences; Janssen; Pfizer; Roche; Takeda |
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Roche; Takeda |
|
|
No Relationships to Disclose |
|
|
Research Funding - Janssen; Roche |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Celgene; Takeda |
Travel, Accommodations, Expenses - Janssen; Takeda |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
Consulting or Advisory Role - Roche |
|